Company news

American Diversified Holdings Corp. news in 2024

American Diversified Holdings Corp.'s news releases, calls and decks from 2024, newest first.

View company

American Diversified Holdings Corporation (ADHC) Retains Dr. Stephen C. Weber, MD, FACS As Head of Medical Advisory Board

November 18, 2024

Glucoguard, a Division of ADHC, Completes AI Based Mobile Application and Design Outline (MADO) for Dexcom API Integration

October 28, 2024

American Diversified Holdings Corporation (ADHC) Completes Acquisition Of GlucoGuard, a AI-Based Medical Device for Managing Nocturnal Hypoglycemia in Diabetic Patients

September 29, 2024

American Diversified Holdings Corporation (ADHC) to Acquire GlucoGuard, a AI-Based Medical Device for Managing Nocturnal Hypoglycemia in Diabetic Patients

September 8, 2024

American Diversified Holdings Corporation Announces the Cancellation of 466 Million Shares

August 28, 2024

American Diversified Holdings Corporation Announces a Major Debt Restructuring Eliminating $2.727 Million in Debt from Their Balance Sheet

August 25, 2024

ADHC to be debt free upon the completion of major debt restructuring

August 26, 2024

American Diversified Holdings corporation launches new artificial intelligence (AI) business division

August 19, 2024

American Diversified Holdings Corporation Launches New Artificial Intelligence (AI) Business Division

August 12, 2024

American Diversified Holdings corporation (OTC: "ADHC") retains bio device veteran, bill colone to advise on entering $585 billion bio device arena

June 3, 2024

American Diversified Holdings corporation targets $595 billion bio device market

May 29, 2024

New CEO, John Cacchioli, Esq. Approved By OTC Markets As Company Charts New Course for 2024

April 24, 2024

American diversfiied holdings corporation appoints new chairman/CEO

February 29, 2024

Resignation of CEO

February 28, 2024

ADHC announces resignation of chairman/CEO

February 22, 2024